ATuM

Founded in 2003 as DNA2.0 and rebranded to ATUM in 2017, the company is a leading bioengineering solutions provider. ATUM's mission is to empower scientific research and development by offering an integrated platform that includes gene synthesis, protein engineering, protein expression, and cell line development services. They leverage proprietary technologies like the Leap-In Transposase® and a machine-learning-based platform to optimize biological components and systems for the development of new therapies, chemicals, and agricultural products.